Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6633)
All Articles published online
|
Publishing Process of This Article
|
Apr 7, 2015 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Jácome AA, Sankarankutty AK, dos Santos JS. Adjuvant therapy for gastric cancer: What have we learned since INT0116? World J Gastroenterol 2015; 21(13): 3850-3859 [PMID: 25852269 DOI: 10.3748/wjg.v21.i13.3850] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v21/i13/3850.htm |
| Number | Citing Articles |
| 1 |
Liying Hou, Haijin Zhang, Peixiang Xu, Lijia Zhang, Xuguang Zhang, Yanpei Sun, Xiaoli Huang, Kun Wu. Effect of vitamin E succinate on the expression of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor in gastric cancer cells and CD4+T cells. Molecular BioSystems 2015; 11(11): 3119 doi: 10.1039/C5MB00350D
|
| 2 |
Milan Vošmik, Jan Laco, Igor Sirák, Josef Dvořák, Petr Lochman, Miroslav Hodek, Petra Malá, Stanislav Rejchrt, Rudolf Repák, Michal Leško, Alexander Ferko, Aleš Ryška, Bohuslav Melichar, Jiří Petera. Histopathologic Features are more Important Prognostic Factors than Primary Tumour Location in Gastro-oesophageal Adenocarcinoma Treated with Preoperative Chemoradiation and Surgery. Pathology & Oncology Research 2018; 24(2): 373 doi: 10.1007/s12253-017-0253-z
|
| 3 |
Roberto Carmagnani Pestana, Shiraj Sen, Brian P. Hobbs, David S. Hong. Histology-agnostic drug development — considering issues beyond the tissue. Nature Reviews Clinical Oncology 2020; 17(9): 555 doi: 10.1038/s41571-020-0384-0
|
| 4 |
Xuechao Liu, Zhiming Wu, Enzi Lin, Wei Li, Yingbo Chen, Xiaowei Sun, Zhiwei Zhou. Systemic prognostic score and nomogram based on inflammatory, nutritional and tumor markers predict cancer-specific survival in stage II–III gastric cancer patients with adjuvant chemotherapy. Clinical Nutrition 2019; 38(4): 1853 doi: 10.1016/j.clnu.2018.07.015
|
| 5 |
Nobuhiko Nakagawa, Mitsuro Kanda, Seiji Ito, Yoshinari Mochizuki, Hitoshi Teramoto, Kiyoshi Ishigure, Toshifumi Murai, Takahiro Asada, Akiharu Ishiyama, Hidenobu Matsushita, Chie Tanaka, Daisuke Kobayashi, Michitaka Fujiwara, Kenta Murotani, Yasuhiro Kodera. Pathological tumor infiltrative pattern and sites of initial recurrence in stage II/III gastric cancer: Propensity score matching analysis of a multi‐institutional dataset. Cancer Medicine 2018; 7(12): 6020 doi: 10.1002/cam4.1868
|
| 6 |
Kholood Abid Janjua, Raheem Shahzad, Adeeb Shehzad. Cancer Biomarkers in Diagnosis and Therapeutics. 2022; : 277 doi: 10.1007/978-981-16-5759-7_11
|
| 7 |
Mitsuro Kanda, Yasuhiro Kodera, Junichi Sakamoto. Updated evidence on adjuvant treatments for gastric cancer. Expert Review of Gastroenterology & Hepatology 2015; 9(12): 1549 doi: 10.1586/17474124.2015.1094373
|
| 8 |
Binglu Huang, Shan Tian, Na Zhan, Jingjing Ma, Zhiwei Huang, Chukang Zhang, Hao Zhang, Fanhua Ming, Fei Liao, Mengyao Ji, Jixiang Zhang, Yinghui Liu, Pengzhan He, Beiying Deng, Jiaming Hu, Weiguo Dong. Accurate diagnosis and prognosis prediction of gastric cancer using deep learning on digital pathological images: A retrospective multicentre study. EBioMedicine 2021; 73: 103631 doi: 10.1016/j.ebiom.2021.103631
|
| 9 |
Roberto Carmagnani Pestana, Nuhad K. Ibrahim. Locoregional Radionuclide Cancer Therapy. 2021; : 17 doi: 10.1007/978-3-030-56267-0_2
|
| 10 |
Karol Polom, Luigi Marano, Giandomenico Roviello, Roberto Petrioli, Riccardo Piagnerelli, Lorenzo de Franco, Daniele Marrelli, Franco Roviello. Evolution and emerging future of cytoreducxtive surgery and hyperthermic intraperitoneal chemoperfusion in gastric cancer: From treating the incurable to preventing recurrence. International Journal of Hyperthermia 2016; 32(2): 173 doi: 10.3109/02656736.2015.1111432
|